Related Experiment Video
Updated: Aug 11, 2026
12:03
Viability Assays for Cells in Culture
Published on: January 20, 2014
Developmental neurotoxicity. Illustration of principles
1Case Western Reserve University, Cleveland, Ohio, USA. cfb3@po.cwru.edu
Pediatric Clinics of North America
|October 3, 2001
Summary
Neurodevelopmental disorders pose a significant challenge, often with unknown causes. This study explores developmental neurotoxins, focusing on L1 cell adhesion molecule, suggesting ethanol
Area of Science:
- Neuroscience
- Toxicology
- Developmental Biology
Background:
- Neurodevelopmental disorders represent a major global health issue.
- The underlying mechanisms of injury are frequently unidentified.
- Developmental neurotoxicology examines environmental factors impacting nervous system development.
Purpose of the Study:
- To discuss common developmental neurotoxins.
- To review the function of the L1 cell adhesion molecule (L1CAM).
- To illustrate principles of developmental neurotoxicology using L1CAM as a model.
Main Methods:
- Literature review of developmental neurotoxins.
- Detailed examination of L1 cell adhesion molecule function.
- Comparative analysis of fetal alcohol syndrome and L1 mutations.
Main Results:
- L1 cell adhesion molecule is essential for central nervous system development.
- Ethanol's developmental neurotoxicity may involve L1CAM.
- Similarities exist between fetal alcohol syndrome and L1 mutation phenotypes.
Conclusions:
- L1CAM plays a critical role in neurodevelopment.
- Ethanol's neurotoxic effects are partly mediated through L1CAM.
- Understanding L1CAM function is key to addressing certain neurodevelopmental disorders.
More Related Videos
09:02Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
07:41A Neurite Outgrowth Assay and Neurotoxicity Assessment with Human Neural Progenitor Cell-Derived Neurons
Published on: August 6, 2020
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:01Neuroplasticity
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...